A multiple biomarker risk score for guiding clinical decisions using a decision curve approach

Advances in Measuring the Effect of Individual Predictors of Cardiovascular Risk: The Role of Reclassification Measures

(2013) Nancy R. Cook et al.   ANNALS OF INTERNAL MEDICINE

Cardiac Troponin T Measured by a Highly Sensitive Assay Predicts Coronary Heart Disease, Heart Failure, and Mortality in the Atherosclerosis Risk in Communities Study

(2011) Justin T. Saunders et al.   CIRCULATION

Potential Use of 10-Year and Lifetime Coronary Risk Information for Preventive Cardiology Prescribing Decisions

(2010) Stephen D. Persell   ARCHIVES OF INTERNAL MEDICINE

Cholesterol Lowering, Cardiovascular Diseases, and the Rosuvastatin-JUPITER Controversy

(2010) Michel de Lorgeril   ARCHIVES OF INTERNAL MEDICINE

Separating the Contenders From the Pretenders

(2010) James A. de Lemos et al.   CIRCULATION

Cost-Effectiveness of Using High-Sensitivity C-Reactive Protein to Identify Intermediate- and Low-Cardiovascular-Risk Individuals for Statin Therapy

(2010) Keane K. Lee et al.   CIRCULATION

Contribution of 30 Biomarkers to 10-Year Cardiovascular Risk Estimation in 2 Population Cohorts

(2010) Stefan Blankenberg et al.   CIRCULATION

Improvement of cardiovascular risk prediction: time to review current knowledge, debates, and fundamentals on how to assess test characteristics

(2010) Michel Romanens et al.   EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION

Prognostic value, clinical effectiveness, and cost-effectiveness of high-sensitivity C-reactive protein as a marker for major cardiac events in asymptomatic individuals: A health technology assessment report

(2010) Petra Schnell-Inderst et al.   INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE

Multimarker Prediction of Coronary Heart Disease Risk

(2010) Hyeon Chang Kim et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Multiple Biomarkers for Predicting Cardiovascular Events

(2010) Thomas J. Wang   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials

(2010) Naveed Sattar et al.   LANCET

Thirty-One Novel Biomarkers as Predictors for Clinically Incident Diabetes

(2010) Veikko Salomaa et al.   PLoS One

Update on integrated biomarkers for assessment of long-term risk of cardiovascular complications in initially healthy subjects and patients with manifest atherosclerosis

(2009) Wolfgang Koenig   ANNALS OF MEDICINE

Effects of Statin Therapy According to Plasma High-Sensitivity C-Reactive Protein Concentration in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)

(2009) John J.V. McMurray et al.   CIRCULATION

Criteria for Evaluation of Novel Markers of Cardiovascular Risk

(2009) Mark A. Hlatky et al.   CIRCULATION

Assessing the Performance of Prediction Models

(2009) Ewout W. Steyerberg et al.   EPIDEMIOLOGY

Thirty-five-year trends in cardiovascular risk factors in Finland

(2009) E. Vartiainen et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

Novel and Conventional Biomarkers for Prediction of Incident Cardiovascular Events in the Community

(2009) Olle Melander   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis

(2009)   LANCET

Statins and Cancer Risk

(2008) Igor Karp et al.   AMERICAN JOURNAL OF MEDICINE

C-Reactive Protein and Parental History Improve Global Cardiovascular Risk Prediction

(2008) Paul M Ridker et al.   CIRCULATION

Use of Multiple Biomarkers to Improve the Prediction of Death from Cardiovascular Causes

(2008) Björn Zethelius et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

(2008) Paul M Ridker et al.   NEW ENGLAND JOURNAL OF MEDICINE